Vitamin E research finds tocotrienols outperform tocopherols in preventing cell death

A study has shown that the vitamin E form tocotrienols is more effective than tocopherols in preventing ferroptosis, a type of cell death. Ferroptosis is driven by iron-dependent lipid peroxidation and is increasingly caused by aging. The new study shows that across multiple experimental models, tocotrienols suppress ferroptosis at lower concentrations compared to tocopherols.

To ensure reproducible findings, the scientists used multiple ferroptosis models, advanced lipid peroxidation assays, and genetic validation. PhytoGaia discusses the findings and how they relate to its tocotrienol ingredient STGaia.

“This study highlights how tocotrienols are more effective in preventing ferroptosis, a key pathway in aging, while squalene provides complementary membrane protection. For the nutraceutical industry, it opens exciting new opportunities for science-backed longevity innovation and product developments,” says Bryan See, VP of PhytoGaia.

“PhytoGaia’s novel and latest branded ingredient – STGaia (synergistic complex of tocotrienols and squalene, naturally extracted from palm fruits) delivers a powerful, dual-lipid approach to support healthy aging at the cellular level.”

Higher efficacy

The study, conducted by researchers at Tohoku University, Japan, also provides mechanistic insight into how tocotrienols more effectively intercept lipid peroxidation cascades central to ferroptotic cell death.

PhytoGaia explains that tocotrienols suppressed lipid peroxidation more effectively, the core biochemical driver of ferroptosis.PhytoGaia details the key findings of the study: “Tocotrienols demonstrated significantly stronger anti-ferroptotic activity than tocopherols across multiple experimental systems, including both chemical–induction and genetic–deletion models.”

“In glutathione peroxidase 4 (GPX-4) deficient ferroptosis models, tocotrienols effectively inhibit ferroptosis, with approximately 15-fold greater potency than tocopherols.”

The company explains that tocotrienols suppressed lipid peroxidation more effectively, the core biochemical driver of ferroptosis, as demonstrated in both cell-free and cellular lipid oxidation assays.

“At biologically effective concentrations, tocotrienols exhibited lower cellular cytotoxicity than commonly used experimental ferroptosis inhibitors,” adds PhytoGaia.

The study has been published in Scientific Reports.

Recent recognition

The recognized form of programmed cell death, ferroptosis, has been more clearly defined in the last decade. Compared with necrosis or apoptosis, ferroptosis is driven by multiple factors: iron overload, lipid peroxidation of cell membranes, and failure of glutathione, GPX4, and other key antioxidant defence systems.

Compared with necrosis or apoptosis, ferroptosis is driven by multiple factors.When this combination of events occurs, it causes rapid and irreversible cell damage. Additionally, research has shown that ferroptosis is a common underlying cause for many chronic diseases, including aging-related inflammation, cardiovascular disease, metabolic conditions, and neurodegenerative disorders.

Therefore, it has emerged as a focus area for disease prevention and therapy, addressing multiple conditions simultaneously.

“Not all forms of vitamin E are created equal,” says Dr. Ariati Aris, scientific affairs specialist at PhytoGaia. “Tocotrienols exhibit superior antioxidant behavior in the specific context of ferroptosis, suggesting they may play an important role in cellular protection than previously recognized.”

“These results provide strong support for the growing interest in tocotrienols in the fields of healthy aging, metabolic health, and oxidative stress management. While further in vivo and clinical studies are needed, these findings position tocotrienols as promising candidates for future nutritional, functional food, and wellness applications,” adds Aris.